OXBRYTA Trademark

Trademark Overview

On Thursday, December 14, 2017, a trademark application was filed for OXBRYTA with the United States Patent and Trademark Office. The USPTO has given the OXBRYTA trademark a serial number of 87721060. The federal status of this trademark filing is REGISTERED as of Tuesday, January 28, 2020. This trademark is owned by Global Blood Therapeutics, Inc.. The OXBRYTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
oxbryta

General Information

Serial Number87721060
Word MarkOXBRYTA
Filing DateThursday, December 14, 2017
Status700 - REGISTERED
Status DateTuesday, January 28, 2020
Registration Number5973583
Registration DateTuesday, January 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 28, 2017
Primary Code005
First Use Anywhere DateTuesday, November 26, 2019
First Use In Commerce DateTuesday, November 26, 2019

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, December 18, 2017NEW APPLICATION ENTERED
Thursday, December 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 26, 2018ASSIGNED TO EXAMINER
Monday, March 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 12, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018SOU EXTENSION 1 FILED
Wednesday, December 12, 2018SOU EXTENSION 1 GRANTED
Tuesday, May 14, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, May 14, 2019SOU EXTENSION 2 FILED
Tuesday, May 14, 2019SOU EXTENSION 2 GRANTED
Thursday, May 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 13, 2019TEAS STATEMENT OF USE RECEIVED
Friday, December 13, 2019SOU EXTENSION 3 FILED
Friday, December 13, 2019USE AMENDMENT FILED
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 13, 2019SOU TEAS EXTENSION RECEIVED
Thursday, December 19, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 19, 2019SOU EXTENSION 3 GRANTED
Thursday, December 19, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, December 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 23, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 24, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 28, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 10, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, February 4, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, November 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 28, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

oxbryta treatment preparations pharmaceutical hypoxic conditions disease hypoxemic such hematological disorders